Genetic analyses report that the severity of ADPKD is higher in truncating than nontruncating PKD1 mutations, and the least disease severity is observed in patients with PKD2 mutations (Cornec‐Le Gall et al., 2013). This evidence concerns the gene PKD2 and autosomal dominant polycystic kidney disease.